You are here

A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis

Last updated on June 6, 2019

FOR MORE INFORMATION
Study Location
Bay Area Physicians for Women
Mobile, Alabama, 36608 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Endometriosis
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-49 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Pre-menstrual women with moderate to severe endometriosis. The diagnosis of
endometriosis must have been confirmed surgically within the last 8 years.

- Subjects should have regular menstrual cycle (21 - 35 days) and must be willing to use
adequate contraception (2 forms of birth control, one of which must be a barrier
method). Contraception is required throughout the study (screening to 16 weeks post
treatment), even if subjects discontinue prematurely.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Previous hysterectomy

- Surgical treatment for endometriosis within last 6 months.

- Medical treatment for endometriosis other than combined oral contraceptive pill within
the last 3 months

- Current use of the coil or progesterone only contraceptive (the combined oral
contraceptive pill is allowed).

- Any history of malignant disease (cancer)

NCT00784693
Pfizer
Terminated
A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now